Literature DB >> 29453216

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states.

Pedro M Machado1, Robert Landewé2,3, Désirée van der Heijde4.   

Abstract

Entities:  

Keywords:  ankylosing spondylitis; disease activity; low back pain; outcomes research; spondyloarthritis

Mesh：

Year:  2018        PMID： 29453216     DOI： 10.1136/annrheumdis-2018-213184

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  35 in total

1.  The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis.

Authors:  Yi-Hsing Chen; Wen-Nan Huang; Yi-Ming Chen; Kuo-Lung Lai; Tsu-Yi Hsieh; Wei-Ting Hung; Ching-Tsai Lin; Chih-Wei Tseng; Kuo-Tung Tang; Yin-Yi Chou; Yi-Da Wu; Chin-Yin Huang; Chia-Wei Hsieh; Yen-Ju Chen; Yu-Wan Liao; Hsin-Hua Chen
Journal:  Front Med (Lausanne)       Date:  2022-05-16

2.  Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis.

Authors:  Zena Chen; Jun Qi; Qiujing Wei; Xuqi Zheng; Xinyu Wu; Xiaomin Li; Zetao Liao; Zhiming Lin; Jieruo Gu
Journal:  Ann Transl Med       Date:  2019-10

3.  Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE.

Authors:  Robert Landewé; Désirée van der Heijde; Maxime Dougados; Xenofon Baraliakos; Filip Van den Bosch; Karl Gaffney; Lars Bauer; Bengt Hoepken; Natasha de Peyrecave; Karen Thomas; Lianne S Gensler
Journal:  Rheumatol Ther       Date:  2020-06-11

4.  Improvement of Disease Management and Cost Effectiveness in Chinese Patients with Ankylosing Spondylitis Using a Smart-Phone Management System: A Prospective Cohort Study.

Authors:  Xiaojian Ji; Yiwen Wang; Yingpei Ma; Zhengyuan Hu; Siliang Man; Ying Zhang; Kunpeng Li; Jinshui Yang; Jian Zhu; Jianglin Zhang; Feng Huang
Journal:  Biomed Res Int       Date:  2019-02-25       Impact factor: 3.411

5.  Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet's disease.

Authors:  Atsuko Katsuyama; Sentaro Kusuhara; Ryuto Nishisho; Wataru Matsumiya; Atsushi Azumi; Makoto Nakamura
Journal:  Clin Ophthalmol       Date:  2019-03-20

6.  Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex.

Authors:  Lucy Law; Jeanette Beckman Rehnman; Anna Deminger; Eva Klingberg; Lennart T H Jacobsson; Helena Forsblad-d'Elia
Journal:  Arthritis Res Ther       Date:  2018-12-27       Impact factor: 5.156

7.  ASDAS is associated with both the extent and intensity of DW-MRI spinal inflammation in active axial spondyloarthritis.

Authors:  Ho Yin Chung; Eva Tsz Fung Chui; Kam Ho Lee; Helen Hoi Lun Tsang; Shirley Chiu Wai Chan; Chak Sing Lau
Journal:  RMD Open       Date:  2019-08-06

8.  Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension.

Authors:  Atul Deodhar; Désirée van der Heijde; Joachim Sieper; Filip Van den Bosch; Walter P Maksymowych; Tae-Hwan Kim; Mitsumasa Kishimoto; Andrew Ostor; Bernard Combe; Yunxia Sui; Alvina D Chu; In-Ho Song
Journal:  Arthritis Rheumatol       Date:  2021-11-12       Impact factor: 15.483

9.  Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label, multicentric study.

Authors:  Ting Zhang; Jianing Zhu; Dongyi He; Xiaowei Chen; Hongzhi Wang; Ying Zhang; Qin Xue; Weili Liu; Guangbo Xiang; Yasong Li; Zhongming Yu; Huaxiang Wu
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-06-02       Impact factor: 5.346

10.  Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries.

Authors:  Daniela Opris-Belinski; Shandor F Erdes; Simeon Grazio; Ladislav Šenolt; Maja Hojnik; Orsolya Nagy; Diana Marina; Sándor Szántó
Journal:  Drugs Context       Date:  2018-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.